Literature DB >> 24906604

Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Xin-Zu Chen1, Wei-Han Zhang, Kun Yang, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Jian-Kun Hu.   

Abstract

The objective of this study is to quantitatively analyze the predictive strength among the conventional serological tumor biomarkers for gastric cancer in Chinese population. Thirty-three hospital-based case-control studies were searched out through Chinese databases and PubMed during 1999-2009. Gastric cancer cases and healthy volunteers or benign gastric diseases controls were detected of any of serological CA724, CA242, CEA, CA199, CA125, or CA153. Areas under the curve (AUC) and optimal Q indexes of summary receiver operating characteristics (sROC) curves were quantitatively compared. The summary positive and negative likelihood ratios (sLR + and sLR-) were pooled. Totally, 2,390 gastric cancer cases and 2,893 controls were analyzed. CA724 and CA242 both had the greatest AUCs (0.88), respectively, followed by the combination CA724 + CEA + CA199 (0.85), CA125 (0.82), CEA (0.80), and CA199 (0.76), but all of them had no statistical significance to CA153 (negative control) by Z tests, possibly due to relatively great standard errors. The results of Q index analyses were similar to those of AUCs, that CA724 and CA242 had the optimal strength. The sLR + of CA724 (16.08, 95 % confidence interval (CI) 7.86-32.86) or CA242 (11.03, 95 % CI 7.12-17.08) was strong to judge the gastric cancer status based on its positive result. The combination of CA724 + CEA + CA199 had the prior sLR- (0.33, 95 % CI 0.25-0.43) to the others. Serological CA724 or CA242 has predictive effect for screening gastric cancer and can be recommended into the screening program of population-based or symptomatic cases. However, prospective epidemiological studies are required before confirmative conclusion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906604     DOI: 10.1007/s13277-014-1986-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].

Authors:  Yu-bing Zhu; Shao-hua Ge; Lian-hai Zhang; Xiao-hong Wang; Xiao-fang Xing; Hong DU; Ying Hu; Ying-ai Li; Yong-ning Jia; Yi Lin; Biao Fan; Jia-fu Ji
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2012-02

Review 2.  Serum pepsinogen and gastric cancer screening.

Authors:  Chizu Mukoubayashi; Kimihiko Yanaoka; Hiroshi Ohata; Kenji Arii; Hideyuki Tamai; Masashi Oka; Masao Ichinose
Journal:  Intern Med       Date:  2007-03-15       Impact factor: 1.271

3.  Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC).

Authors:  S Folli; P Morgagni; F Roviello; G De Manzoni; D Marrelli; L Saragoni; A Di Leo; M Gaudio; O Nanni; A Carli; C Cordiano; D Dell'Amore; A Vio
Journal:  Jpn J Clin Oncol       Date:  2001-10       Impact factor: 3.019

4.  Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer.

Authors:  J S Lee; S Park; J M Park; J H Cho; S I Kim; B-W Park
Journal:  Ann Oncol       Date:  2012-12-09       Impact factor: 32.976

Review 5.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

6.  Short-term evaluation of laparoscopy-assisted distal gastrectomy for predictive early gastric cancer: a meta-analysis of randomized controlled trials.

Authors:  Xin-Zu Chen; Jian-Kun Hu; Kun Yang; Li Wang; Qing-Chun Lu
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-08       Impact factor: 1.719

Review 7.  [Determination of the tumor marker CA 72-4 in gastric carcinoma].

Authors:  E Martín-Pérez; M Fernández-Arjona; B Baza; C Villanueva; E Larrañaga; P A Serrano; A Clerigué
Journal:  Rev Esp Enferm Dig       Date:  1993-02       Impact factor: 2.086

8.  Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence.

Authors:  B Joypaul; M Browning; E Newman; D Byrne; A Cuschieri
Journal:  Am J Surg       Date:  1995-06       Impact factor: 2.565

9.  Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.

Authors:  M Ychou; J Duffour; A Kramar; S Gourgou; J Grenier
Journal:  Dis Markers       Date:  2000       Impact factor: 3.434

10.  Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer.

Authors:  F Safi; V Kuhns; H G Beger
Journal:  Int J Biol Markers       Date:  1995 Apr-Jun       Impact factor: 3.248

View more
  6 in total

Review 1.  Diagnosis of tuberculosis pleurisy with adenosine deaminase (ADA): a systematic review and meta-analysis.

Authors:  Xuwei Gui; Heping Xiao
Journal:  Int J Clin Exp Med       Date:  2014-10-15

2.  Multiple cytokine profiling in serum for early detection of gastric cancer.

Authors:  Jian Li; Liang Xu; Zeng-Ci Run; Wen Feng; Wen Liu; Peng-Jun Zhang; Zhi Li
Journal:  World J Gastroenterol       Date:  2018-06-07       Impact factor: 5.374

3.  Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: The protocol of a systematic review and meta-analysis based on epidemiological studies.

Authors:  Rui Wang; Kai Liu; Xin-Zu Chen
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.

Authors:  Kam-Fai Lee; Ming-Ming Tsai; Chung-Ying Tsai; Chung-Guei Huang; Yu-Hsiang Ou; Ching-Chuan Hsieh; Hsi-Lung Hsieh; Chia-Siu Wang; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-11-13       Impact factor: 5.923

5.  The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients.

Authors:  Jiaan Kuang; Yizhen Gong; Hailun Xie; Ling Yan; Shizhen Huang; Feng Gao; Shuangyi Tang; Jialiang Gan
Journal:  PeerJ       Date:  2020-04-14       Impact factor: 2.984

6.  Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Hai-Ning Chen; Jian-Ping Liu; Du He; Yang Liu; Kai Liu; Xiao-Long Chen; Xian-Ming Mo; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.